We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Vienna, Austria

ESTRO 2025

Session

Monday
May 05
10:30 - 11:30
Business 1-2
CNS 1
Hela Hammami, Tunisia;
Luca Visani, Italy
Mini-Orals are presented at one of the sessions scheduled in the two mini-oral theatres. Each author will present a 4-slide PowerPoint orally for 4 minutes, followed by 3 minutes for discussion. Sessions will be recorded and made available via the online platform and mobile app.
Mini-Orals
Clinical
CNS
10:30 - 10:37
Stereotactic radiosurgery for uveal melanoma – long-term outcomes and volumetric analysis
Jakub Cvek, Czech Republic
E25-3191
10:37 - 10:44
Dose-response modelling of stereotactic radiosurgery for brain metastases: preliminary prospective data from the SAFER study (IRAS 276567)
James de Boisanger, United Kingdom
E25-2032
10:44 - 10:51
International collaboration of neoadjuvant stereotactic radiosurgery for brain metastases: the INTERNEO individual patient data pooled analysis
Susanne Rogers, Switzerland
E25-1440
10:51 - 10:58
Planned interim analysis of PREOP-2 randomised trial (NCT05124236): low toxicity and high feasibility of preoperative SRS for brain metastases.
Susanne Rogers, Switzerland
E25-345
10:58 - 11:05
Oncological outcome of re-irradiation for recurrent glioblastoma – Results of a prospective multicenter trial (GLIAA, NCT01252459)
Ilinca Popp, Germany
E25-2401
11:05 - 11:12
Adult newly malignant brainstem glioma treated with anlotinib plus radiotherapy: a multicenter, phase II study
Yuan-yuan Chen, China
E25-1995
11:12 - 11:19
Recurrence pattern analysis following glioblastoma radiotherapy with reduced CTV margins
Alexander Nitschmann, Germany
E25-2993
11:19 - 11:26
Estimating Radiation Necrosis Risk following Single-fraction Stereotactic Radiosurgery in the Modern Era: An In-Depth Dose-Volume Analysis
Rupesh Kotecha, USA
E25-2775